Journal of Business Chemistry – M&A in the pharmaceutical industry

In parallel with the slowdown of the global economy M&A markets massively decreased during the last two years. However, strategic buyers within the pharmaceutical industry are clearly an exceptional case. With mega deals like Pfizer/Wyeth and Merck & Co./Schering-Plough in year 2009 and a strong year 2010 start (e.g. Teva/Ratiopharm, Merck/Millipore) the wheel in Pharma-M&A keeps on turning.